Epigallocatechin gallate reduces human monocyte mobility and adhesion in vitro.
about
Developing and applying the adverse outcome pathway concept for understanding and predicting neurotoxicityThe brominated compound aeroplysinin-1 inhibits proliferation and the expression of key pro- inflammatory molecules in human endothelial and monocyte cellsGreen tea polyphenol epigallocatechin-3-gallate: inflammation and arthritis. [corrected].Epigallocatechin-3-gallate suppresses the global interleukin-1beta-induced inflammatory response in human chondrocytes.Epigallocatechin-3-gallate Inhibits LPS-Induced NF-κB and MAPK Signaling Pathways in Bone Marrow-Derived MacrophagesA Unique Combination of Nutritionally Active Ingredients Can Prevent Several Key Processes Associated with Atherosclerosis In Vitro.(-)-Epigallocatechin gallate inhibits endotoxin-induced expression of inflammatory cytokines in human cerebral microvascular endothelial cells.Formulation, characteristics and antiatherogenic bioactivities of CD36-targeted epigallocatechin gallate (EGCG)-loaded nanoparticles.Protective effect of epigallocatechin-3-gallate (EGCG) via Nrf2 pathway against oxalate-induced epithelial mesenchymal transition (EMT) of renal tubular cells.Nanoencapsulation enhances epigallocatechin-3-gallate stability and its antiatherogenic bioactivities in macrophagesImmunomodulating effects of epigallocatechin-3-gallate from green tea: mechanisms and applications.Biophysical characteristics of proteins and living cells exposed to the green tea polyphenol epigallocatechin-3-gallate (EGCg): review of recent advances from molecular mechanisms to nanomedicine and clinical trials.Epigallocatechin gallate (EGCG) inhibits adhesion and migration of neural progenitor cells in vitro.Epigallocatechin-3-gallate protects kidneys from ischemia reperfusion injury by HO-1 upregulation and inhibition of macrophage infiltration.Improvement of leucocyte functions in mature and old mice after 15 and 30 weeks of diet supplementation with polyphenol-rich biscuits.High-Resolution Adhesion Kinetics of EGCG-Exposed Tumor Cells on Biomimetic Interfaces: Comparative Monitoring of Cell Viability Using Label-Free Biosensor and Classic End-Point Assays.
P2860
Q28394433-BD347D3A-3749-4F6C-84DF-7E3AFB8FFBC0Q28485319-DC0615F8-8E7A-421E-AD53-EED05E1D5186Q35135845-038DD1EE-D477-4EAE-829E-441BF5FF1133Q35557911-26E0DAAB-AC4F-46B7-B873-3DBF447B3165Q35931200-A53174C5-5078-4E53-90B4-C690F322F7BCQ35948024-87A72F15-D3C6-411F-B57C-9839FA4CB159Q36127742-6B44DD7B-A949-4C1F-821B-74177A725410Q36731084-1E190F26-CE67-41E0-83D7-6BC7C21011BDQ37121791-AE83D910-C04A-465C-AAD6-BEF4AD4491B8Q37341571-9B99CA52-64A1-4767-9C49-9D709AA08DFCQ38120159-9F876CAB-E24B-4118-B468-394D8A7C264EQ38851914-1C0367B1-465F-405B-BBA0-CA1141488ECCQ39820524-D3271349-B256-4976-A272-984A080D1634Q50527406-A788986E-FD03-415A-8619-EACE5903274EQ51518425-D870DD5A-D06C-4905-9A62-85DAF35B063FQ54988565-37C972D1-818F-4D46-B8DC-92AC49B86849
P2860
Epigallocatechin gallate reduces human monocyte mobility and adhesion in vitro.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Epigallocatechin gallate reduces human monocyte mobility and adhesion in vitro.
@en
Epigallocatechin gallate reduces human monocyte mobility and adhesion in vitro.
@nl
type
label
Epigallocatechin gallate reduces human monocyte mobility and adhesion in vitro.
@en
Epigallocatechin gallate reduces human monocyte mobility and adhesion in vitro.
@nl
prefLabel
Epigallocatechin gallate reduces human monocyte mobility and adhesion in vitro.
@en
Epigallocatechin gallate reduces human monocyte mobility and adhesion in vitro.
@nl
P2093
P2860
P1476
Epigallocatechin gallate reduces human monocyte mobility and adhesion in vitro.
@en
P2093
Esther Melgarejo
Francisca Sánchez-Jiménez
José Luis Urdiales
P2860
P304
P356
10.1111/J.1476-5381.2009.00452.X
P407
P577
2009-12-01T00:00:00Z